Menopause after breast cancer: symptoms & treatment
Updated: Oct 29
By Dr Jacqueline Radley, BMS-registered Menopause Specialist · Last reviewed: 12th September 2026
If breast cancer treatment has brought on your menopause, or you have had breast cancer and are now going through menopause naturally, this guide is for you. Symptoms in this situation are often more severe, and they are often dismissed or left unaddressed. There is more that can be done than many women realise.
I run a dedicated NHS menopause clinic for women who have had breast cancer, alongside a specialist oncologist colleague at University Hospitals Birmingham (Solihull), and the menopause that follows breast cancer – whether brought on by treatment or occurring naturally – is one of the least well-supported parts of many women's recovery.
This blog sets out what I would want you to know, whatever stage you are at, including:
Why breast cancer treatment can bring on menopause symptoms
Menopause happens when oestrogen levels fall and stay low, whether naturally or because of medical treatment. This is not the same as the natural rise and fall of oestrogen during the menstrual cycle: at menopause, the drop is sustained rather than temporary. It is this lasting fall that produces the familiar symptoms: hot flushes, mood changes, vaginal dryness and more, because oestrogen affects so many systems in the body.
Breast cancer treatment can bring on the same low-oestrogen state as natural menopause, or block some of the effects of oestrogen in several ways. Some are permanent and some are temporary, and knowing which applies to you helps make sense of your symptoms and options.
Chemotherapy
Chemotherapy can damage the ovaries and the eggs they contain. Some drugs are more likely to do this than others, and older women are more at risk, because they have fewer eggs left. This egg loss can bring on menopause, sometimes suddenly. In younger women, the ovaries sometimes recover afterwards; in others, the change is permanent.
Hormone-blocking treatments
Around 70 to 80% of breast cancers are oestrogen receptor-positive, meaning the cancer cells carry receptors that respond to oestrogen. Treatment for these cancers often aims to lower oestrogen levels in the body, or block oestrogen from reaching those cells, and because oestrogen is what falls at menopause, this treatment brings on a menopausal state alongside treating the cancer. There are a few ways of doing this.
Tamoxifen
Tamoxifen is a selective oestrogen receptor modulator, usually prescribed for five to ten years, that blocks oestrogen from acting on breast cancer cells rather than lowering oestrogen levels. It commonly causes hot flushes, night sweats, vaginal symptoms, and mood changes.
Aromatase inhibitors
Aromatase inhibitors (anastrozole, letrozole, exemestane) work differently: they block the enzyme the body uses to make oestrogen, so circulating levels fall substantially. They are used mainly in postmenopausal women, or in premenopausal women whose ovaries have been suppressed. Hot flushes, night sweats, vaginal dryness, and sleep disturbance are common, but joint pain and stiffness can be particularly severe.
GnRH analogues
GnRH analogues (gonadotrophin-releasing hormone analogues) such as goserelin switch off ovarian function directly, often alongside tamoxifen or an aromatase inhibitor in premenopausal women. This can be temporary or permanent.
Surgical menopause
Some women, for example those with a BRCA gene variant, have their ovaries removed as part of treatment or risk reduction. This brings on immediate, permanent menopause, with oestrogen, progesterone, and testosterone all dropping at once, and symptoms are usually significant.
Natural menopause after treatment
Some women reach a natural menopause in the years after treatment finishes. Even then, a history of breast cancer changes how we think about managing symptoms, especially where HRT is concerned.
Menopause symptoms after breast cancer
The symptoms themselves are broadly the same as natural menopause:
Hot flushes and night sweats, which can be frequent and disruptive
Poor sleep and fatigue
Low mood, anxiety, and emotional sensitivity
Brain fog, poor concentration, and memory difficulties
Joint pain and stiffness, particularly with aromatase inhibitors
Vaginal dryness, discomfort, and bladder changes, together known as genitourinary syndrome of menopause (GSM)
Reduced libido
Changes in skin and hair
Weight gain
But they can arrive far more suddenly, hit harder, and be made worse by ongoing hormone-blocking treatment.
Can you take HRT after breast cancer?
The short answer is that HRT which works throughout the body, known as systemic HRT, is not routinely offered after breast cancer, and non-hormonal options are usually tried first. It can still be considered in carefully selected cases, where symptoms are severe, other options have not worked, and your oncology team is fully involved.
For most women going through natural menopause, HRT is the most effective treatment. It works by replacing the oestrogen your body has stopped making, which is what settles the symptoms. After breast cancer, the picture is more complicated, and this has been a source of anxiety for patients and clinicians alike for years.
To understand why, it helps to separate two questions. The first is whether HRT causes breast cancer in women who have never had it. This is the fear many people carry, often shaped by past studies and headlines. In reality the added risk is small, and comparable to, or lower than, other everyday factors such as obesity or regular alcohol use. For the general population, that is reassuring.
However, that reassurance is about developing breast cancer for the first time. If you have already had breast cancer, the question is different, and this is where the oestrogen link matters.
Most breast cancers, as we saw earlier, are oestrogen receptor-positive, meaning they are fuelled by oestrogen, which is why much of the treatment works by lowering or blocking it. Systemic HRT does the opposite: it adds oestrogen back. The concern is that this could work against that treatment and raise the chance of the cancer returning. The evidence here is less clear-cut and much more individual, which is why your own history matters so much.
This is why both NICE and the BMS are clear that systemic HRT is not routinely offered after breast cancer, and that non-hormonal options should be tried first. Both accept that HRT can be considered on a case-by-case basis where symptoms are severe, other options have not worked, and there is full specialist involvement with shared decision-making.
Vaginal oestrogen after breast cancer
Vaginal oestrogen is different to systemic HRT, which works throughout the body. Applied locally to the vagina and vulva, it treats dryness, discomfort, pain with intercourse, and recurrent urinary infections. Because so little of it reaches the bloodstream, it is generally considered safe after breast cancer, including for women on tamoxifen. For those on an aromatase inhibitor, it is usually an individual decision made with your oncologist and breast team.
Vaginal dryness is one of the most common reasons women come off their aromatase inhibitor altogether, so treating it properly is about helping you stay on the treatment that is protecting you, not just about comfort. These symptoms are common and treatable, so mention it if it is affecting you.
Vaginal oestrogen comes as a pessary, cream, gel, or ring, and it takes eight to twelve weeks to build up its effect. You can read more about the different forms of vaginal oestrogen on our treatment information page.
Another non-systemic treatment for menopause-related vaginal symptoms is Prasterone (Intrarosa), a pessary containing DHEA (dehydroepiandrosterone, a natural steroid hormone which gets converted to sex hormones like testosterone and oestrogen) that works locally in the vaginal tissue. However, the evidence for use after breast cancer is limited, and it is worth discussing with your oncology and menopause team before starting.
Non-hormonal options for menopause after breast cancer
For many women after breast cancer, non-hormonal treatment is the mainstay, whether because HRT is not appropriate or because you would rather avoid hormones. The range of options has grown considerably in recent years.
Veoza (fezolinetant)
Veoza is a non-hormonal tablet that can ease hot flushes and night sweats (together known as vasomotor symptoms) without using any oestrogen. It works on the part of the brain that helps control body temperature. When oestrogen falls, a neurokinin pathway (a signalling system in the brain) becomes overactive and sets off hot flushes, and Veoza calms that signal down.
In March 2026, NICE recommended Veoza for NHS use* in women for whom HRT is unsuitable. This recent guidance discusses use around breast cancer specifically, it is not recommended for women who currently have breast cancer.
For those who have had breast cancer and finished treatment, Veoza may be an option, but it is a decision to weigh up individually with your specialist and your oncology team. Clinical trials have not yet studied its use after breast cancer treatment, so an individual discussion that weighs up the benefits and the unknowns, with full informed consent, is essential.
Taking Veoza requires routine blood tests to check your liver, which I will talk you through if we are considering it.
Lynkuet (elinzanetant)
Lynkuet is a newer non-hormonal option that, like Veoza, acts on neurokinin (signalling) pathways in the brain. Where Veoza acts on one of the brain signals that trigger hot flushes, Lynkuet acts on two, and it can also help with the disturbed sleep that often comes with them. The UK was the first country in the world to approve it, in July 2025.
Lynkuet has been studied specifically in women taking endocrine therapy (hormone-blocking treatments) such as tamoxifen or an aromatase inhibitor, which reduce the risk of breast cancer returning. A trial published in 2025 showed significant reductions in hot flushes and night sweats, alongside better sleep and quality of life, with reassuring safety data over a year of treatment. Its UK licence was extended in July 2026 to cover exactly this: vasomotor symptoms caused by those hormone-blocking treatments for breast cancer, making it the first medicine specifically licensed in the UK for this use.
In practice, this means that if you are on tamoxifen or an aromatase inhibitor and struggling with hot flushes, Lynkuet is now an on-licence option to discuss. However, NICE has not yet appraised it for NHS funding, so it remains available on private prescription only.
Other non-hormonal medications
Several non-hormonal medicines can help with hot flushes, mood, and sleep. Certain antidepressants (SSRIs and SNRIs), clonidine, gabapentin, and pregabalin all have evidence behind them for vasomotor symptoms, and some clinicians also use oxybutynin off-licence for hot flushes. Each has its own possible side effects, so which one suits you depends on what else is going on, particularly sleep and mood. Many of these can be prescribed on the NHS by your GP once we have agreed a plan, though that depends on your GP; we can make the request on your behalf.
Vaginal moisturisers and lubricants
Beyond vaginal oestrogen, non-hormonal vaginal moisturisers and lubricants, available over the counter, can make a real difference to dryness and discomfort.
Look for ones described as pH-balanced and low-osmolality (sometimes labelled iso-osmolar), meaning they are close to your body's own natural environment. Products that are too alkaline, or too concentrated compared with your own tissue fluid, can irritate the delicate skin or draw moisture out rather than adding it, making dryness worse rather than better.
Silicone-based lubricants tend to be gentler in this respect, though they are not suitable with all barrier contraception or certain toys, so check the packaging. If you are unsure what to look for, I am happy to suggest specific products in your consultation.
Psychological and lifestyle support
Alongside the medical treatments we've discussed so far, there are non-pharmaceutical approaches that can make a real difference to your daily symptoms and wellbeing.
Psychological support
Cognitive behavioural therapy (CBT) has good evidence for hot flushes, sleep, and mood in menopause, including after breast cancer. Some women also find relaxation techniques and paced breathing can take the edge off hot flushes.
In a UK trial run specifically with women who had been treated for breast cancer (MENOS 1), group CBT reduced how much hot flushes and night sweats bothered them by around 46%, with lasting gains in mood, sleep and quality of life. The British Menopause Society recognises it as a helpful non-medical option for hot flushes, sleep and mood, and NICE now recommends menopause-specific CBT for these symptoms. It can be delivered one-to-one, in a group, or through guided self-help.
Relaxation and paced breathing are often taught as part of these CBT programmes; on their own the evidence is more limited, but some women find them a helpful way to cope.
Lifestyle
Staying physically active is one of the most valuable things you can do after breast cancer. As well as easing symptoms and lifting mood, regular activity is linked to better health and survival after breast cancer, and the World Cancer Research Fund recommends that women who have had breast cancer aim to be physically active, in line with the general WHO guidance of at least 150 minutes of moderate activity a week, such as brisk walking, plus muscle-strengthening on two days. Weight-bearing and resistance exercise also help protect bone health, which matters because both low oestrogen and aromatase inhibitors can accelerate bone loss.
Alongside this, keeping to a healthy weight, cutting back on alcohol and caffeine, stopping smoking, and building in good sleep habits all help with symptoms and with general health after breast cancer.
Why specialist care matters, and what to expect
Managing menopause after breast cancer takes time: a full history, an understanding of your specific cancer and its treatment, an honest conversation, and good communication with your oncology team, more than a routine appointment can usually offer.
If your symptoms are not being properly addressed, a private consultation can offer the time and depth that can be hard to find elsewhere. I will always involve your oncology team where relevant, and make sure any plan we agree is communicated clearly to everyone involved in your care.
A consultation for menopause after breast cancer takes longer than a standard appointment, because there is more ground to cover:
Your cancer diagnosis, type, and stage
Your treatment history: surgery, chemotherapy, radiotherapy, hormone-blocking treatments
Your current medications and any ongoing treatment
Your full symptom picture: physical, psychological, and genitourinary
What matters most to you
Your medical history, family history, and lifestyle
The evidence and options relevant to your specific situation
A personalised plan, agreed together
Afterwards, I write a full letter to you, your GP, and, where relevant, your oncology team, setting out what we discussed and agreed.
You can find appointment types, fees, and how to book on our consultations page.
Frequently asked questions
Can you take HRT after breast cancer?
Whole-body HRT (known as systemic HRT) is not routinely offered after breast cancer, and non-hormonal options are usually tried first. In carefully selected cases, where symptoms are severe and other options have not helped, it can be considered with full involvement of your oncology team and shared decision-making. It is an individual decision, not a blanket yes or no.
Is vaginal oestrogen safe after breast cancer?
For vaginal dryness and discomfort, vaginal oestrogen is generally considered safe after breast cancer, including for women on tamoxifen, because very little of it reaches the bloodstream. If you are on an aromatase inhibitor, it is usually an individual decision made with your oncologist and breast team. Vaginal symptoms are common, treatable, and worth mentioning if they are affecting you.
What can I take for hot flushes if I can't have HRT?
There are effective non-hormonal options. Newer medicines such as Lynkuet and Veoza act on the brain pathways behind hot flushes, and Lynkuet is now licensed specifically for hot flushes caused by breast cancer hormone treatments. Certain antidepressants, gabapentin, and clonidine can also help, as can CBT and lifestyle changes. The right choice depends on your situation, particularly your sleep, mood, and whether you are on tamoxifen.
Does tamoxifen cause menopause?
Tamoxifen does not lower your oestrogen levels; it blocks oestrogen from acting on breast cancer cells. However, it commonly brings on menopausal symptoms such as hot flushes, night sweats, vaginal symptoms, and mood changes, because of its oestrogen-blocking effects, so it can feel like menopause even though the underlying mechanism is different.
Can Dr Radley help with menopause after breast cancer?
Yes. I run a dedicated NHS menopause clinic for women who have had breast cancer, alongside a specialist oncologist colleague, and I see private patients in the same situation. I will review your cancer history and treatment, work through the options relevant to you, and always involve your oncology team where it matters. You can book a consultation or get in touch with any questions.
About Dr Jacqueline Radley
Dr Jacqueline Radley is a BMS-registered Menopause Specialist with over 38 years of clinical experience and the Advanced Certificate in Menopause Care. She runs a dedicated NHS menopause clinic for women who have had breast cancer, alongside a specialist oncologist colleague, and has spoken on the subject at breast cancer centres, charity events, and professional education days. She offers private consultations in Birmingham, Worcestershire, and online across the UK.
Comments